Home Diseases Chagas Portfolio

Portfolio

Attention: open in a new window. PDFPrint


Portfolio

By 2014, DNDi aims to deliver from its Chagas-specific portfolio:
  • 1 new paediatric strength available
  • 1 new drug registered






For more details on each project, see DNDi's Global Portfolio


Except where otherwise noted, content on this site is licensed under
a Creative Commons Attribution-Noncommercial-Share Alike 2.5 Switzerland License